Literature DB >> 2891620

Bacteroides gingivalis fimbriae stimulate production of thymocyte-activating factor by human gingival fibroblasts.

S Hanazawa1, K Hirose, Y Ohmori, S Amano, S Kitano.   

Abstract

In a previous report (Y. Ohmori, S. Hanazawa, S. Amano, T. Miyoshi, K. Hirose, and S. Kitano, infect. Immun. 55:947-954, 1987), we showed that human gingival fibroblasts spontaneously produce thymocyte-activating factor (FTAF), which stimulates mitogen-induced thymocyte proliferation. In the present study, we examined the effect of Bacteroides gingivalis fimbriae on FTAF production by the cells, because the fimbriae may be involved in attachment of the organism to periodontal tissues. We show here that the fimbriae bind to the cells, which may subsequently lead to the stimulation of FTAF production by the cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891620      PMCID: PMC259269          DOI: 10.1128/iai.56.1.272-274.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Humoral antibody response against Bacteroides gingivalis-specific antigen recognized by monoclonal antibody in adult periodontal patients.

Authors:  T Miyoshi; S Hanazawa; K Hirose; K Saitoh; S Amano; Y Ohmori; S Kitano
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Increased thymocyte-activating factor in human gingival fluid during gingival inflammation.

Authors:  J A Charon; T A Luger; S E Mergenhagen; J J Oppenheim
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

3.  Fimbriae from the oral anaerobe Bacteroides gingivalis: physical, chemical, and immunological properties.

Authors:  F Yoshimura; T Takasawa; M Yoneyama; T Yamaguchi; H Shiokawa; T Suzuki
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

4.  Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

Authors:  A Fontana; F Kristensen; R Dubs; D Gemsa; E Weber
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effect on their proliferation.

Authors:  Y Ohmori; S Hanazawa; S Amano; T Miyoshi; K Hirose; S Kitano
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  Functional role of interleukin 1 in periodontal disease: induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice.

Authors:  S Hanazawa; K Nakada; Y Ohmori; T Miyoshi; S Amano; S Kitano
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis.

Authors:  F Yoshimura; K Takahashi; Y Nodasaka; T Suzuki
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

8.  Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periondontal disease.

Authors:  C Mouton; P G Hammond; J Slots; R J Genco
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.

Authors:  T A Luger; B M Stadler; B M Luger; B J Mathieson; M Mage; J A Schmidt; J J Oppenheim
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

  9 in total
  35 in total

1.  Porphyromonas gingivalis fimbriae inhibit caspase-3-mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via extracellular signal-regulated kinase-dependent expression of p21 Cip/WAF1.

Authors:  K Ozaki; S Hanazawa
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Porphyromonas gingivalis fimbrillin is one of the fibronectin-binding proteins.

Authors:  Y Murakami; H Iwahashi; H Yasuda; T Umemoto; I Namikawa; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  CpG motifs in Porphyromonas gingivalis DNA stimulate interleukin-6 expression in human gingival fibroblasts.

Authors:  A Takeshita; K Imai; S Hanazawa
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Isolation and characterization of fimbriae from a sparsely fimbriated strain of Porphyromonas gingivalis.

Authors:  H T Sojar; N Hamada; R J Genco
Journal:  Appl Environ Microbiol       Date:  1997-06       Impact factor: 4.792

6.  Porphyromonas gingivalis fimbriae use beta2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 beta chain plays a functional role in fimbrial signaling.

Authors:  A Takeshita; Y Murakami; Y Yamashita; M Ishida; S Fujisawa; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis.

Authors:  A Amano; H T Sojar; J Y Lee; A Sharma; M J Levine; R J Genco
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611.

Authors:  K Matsushita; S Nagaoka; R Arakaki; Y Kawabata; K Iki; M Kawagoe; H Takada
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response.

Authors:  Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.